Tristel PLC
OTC: TSNLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Matthew Giovanni Sassone
- Employees
- 233
- Headquarters
- Snailwell, United Kingdom
- IPO year
- 2014
- Market cap
- $265.4M
- Website
- https://tristel.com
Loading TSNLF…
Loading profile data…Frequently asked questions about TSNLF
What does Tristel PLC (TSNLF) do?
Operating both within the United Kingdom and globally, Tristel plc specializes in the development, production, and distribution of products designed for infection control. Its business is structured into three primary divisions: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and a third, unnamed 'Other' seg...
Where does TSNLF trade?
Tristel PLC (TSNLF) trades on the Other OTC.
What sector is TSNLF in?
Tristel PLC (TSNLF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Tristel PLC?
Matthew Giovanni Sassone is the chief executive officer of Tristel PLC (TSNLF).
Where is Tristel PLC headquartered?
Tristel PLC is headquartered in United Kingdom.
Does TSNLF pay a dividend?
Yes — Tristel PLC (TSNLF) paid a trailing twelve-month dividend of USD 0.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TSNLF go public?
Tristel PLC (TSNLF) completed its initial public offering in 2014.